# Major Recall Alert: OraVerse Recalled Due to Distribution to Unlicensed Wholesalers
On [insert date here], a significant recall was issued for the prescription medication **OraVerse** due to its distribution to wholesalers who do not hold the required establishment license. This recall raises serious regulatory concerns and emphasizes the importance of maintaining strict compliance in the pharmaceutical supply chain. If you use OraVerse or work within the healthcare industry, here's everything you need to know about this issue and how it could affect you.
## Why This Recall is Important
Prescription medications like OraVerse play a vital role in patient care and must comply with stringent regulatory requirements. When a prescription drug is distributed to wholesalers without the appropriate establishment license, it may compromise patient safety, supply chain integrity, and regulatory compliance standards.
Health Canada, the official regulator, closely monitors the distribution of pharmaceuticals to ensure safety and efficacy. This recall is a reminder of why adherence to licensing rules is critical to prevent potential risks to public health.
## Details of the Recall
Here are the essential details of the OraVerse recall:
- **Category**: Prescription drug recall due to distribution to unlicensed wholesalers.
- **Product**: OraVerse (brand and product are the same).
- **Brand**: OraVerse.
- **Recall Reason**: The product was distributed to wholesaler(s) who did not hold an establishment license.
- **Date Announced**: [Insert date or 30632 as placeholder].
- **Issued By**: Health Canada.
For more official information, refer to Health Canada’s notice: [Read the recall notice here](https://recalls-rappels.canada.ca/en/alert-recall/oraverse-distribution-wholesalers-who-do-not-hold-establishment-license-sale-product).
Stay informed about recalls like this to ensure you're using pharmaceuticals that meet proper regulatory standards.
## What You Should Do
If you use or prescribe OraVerse, take the following steps immediately:
- **Check stock**: Review your current inventory of OraVerse to confirm if the products align with the affected batches in the recall notice.
- **Healthcare professionals**: If your clinic or workplace has purchased OraVerse from an unlicensed wholesaler, stop using the product and contact your supplier.
- **Patients**: If you suspect you have used OraVerse distributed from an unlicensed source, consult your healthcare provider for advice.
- **Report concerns**: Contact Health Canada directly if you identify issues or require further guidance.
These proactive steps can help minimize potential risks and ensure patient safety.
## Stay Safe – Get Instant Recall Alerts
Health and safety should always come first. With recalls affecting everything from food to pharmaceuticals, staying informed is more important than ever. The OraVerse recall is a key example of how distribution issues can pose significant risks.
To stay updated on all new recalls and relevant safety alerts, **download our free Recall App today**! You'll gain instant access to recall notifications, valuable insights, and guidance to protect yourself and your loved ones.
### Why Choose the Recall App?
- Instant alerts for product recalls.
- User-friendly information tailored to your safety needs.
- Updated constantly with the latest Health Canada recall notices.
**[Download the Recall App Now](#)** and never miss a vital safety warning again.
---
Stay safe and vigilant by keeping track of critical recalls like the OraVerse distribution alert. For the official Health Canada notice, visit the link here: [OraVerse Recall Notice](https://recalls-rappels.canada.ca/en/alert-recall/oraverse-distribution-wholesalers-who-do-not-hold-establishment-license-sale-product).